>100 Views
August 13, 25
スライド概要
The global Parenteral Packaging Market value is expected to total USD 12,791.2 million by 2024. Over the forecast period, parenteral packaging demand is poised to grow with a CAGR of 4.6%, taking the total market valuation to USD 20,115.6 million by 2034.
Parenteral packaging encompasses materials and systems designed for sterile pharmaceutical preparations administered via injection or infusion. These packaging solutions are vital in protecting drugs from contamination, ensuring stability, and facilitating safe administration. The escalating prevalence of chronic diseases and the subsequent rise in injectable therapies have significantly bolstered the demand for effective parenteral packaging solutions.
Get Your Sample of Our Industry Overview Today! https://www.futuremarketinsights.com/reports/sample/rep-gb-1258
Global Parenteral Packaging Market Expands as Demand for Injectable Drugs and Biologics Surges
The parenteral packaging market is witnessing significant growth, driven by the rising demand for injectable drugs, biologics, and vaccines. With advancements in biopharmaceuticals and the increasing prevalence of chronic diseases, the need for safe, sterile, and high-quality packaging solutions has intensified. The surge in global vaccination programs, particularly in response to pandemics and infectious diseases, has further accelerated demand.
Additionally, the pharmaceutical industry’s focus on patient safety, extended shelf life, and regulatory compliance has led to innovations in glass and plastic vials, ampoules, prefilled syringes, and IV containers. As the healthcare sector continues to expand, the demand for parenteral packaging is expected to rise, making it a critical component in ensuring drug efficacy and patient well-being.
Key Trends Shaping the Parenteral Packaging Market
1. Innovation in Material Science – The industry is witnessing a transition toward advanced materials such as cyclic olefin polymers (COP) and cyclic olefin copolymers (COC), which provide superior moisture and oxygen barrier properties compared to conventional glass.
2. Prefilled Syringes in High Demand – The prefilled syringe segment is gaining immense traction due to its ability to reduce contamination risks, improve dosing accuracy, and enhance ease of use. With biologic drug formulations becoming more complex, pharmaceutical manufacturers are increasingly turning to prefilled solutions to streamline drug administration.
Key Takeaways from the Global Parenteral Packaging Market
• The global market for parenteral packaging is expected to total a valuation of USD 20,115.6 million in 2034.
• By product type, the prefilled syringes segment is projected to grow at 5.3% CAGR through 2034.
• Based on material, the plastic segment will likely hold a market share of 56.1% in 2034.
• Sales in the United States are expected to soar at 3.0% CAGR through 2034.
• India is poised to register a CAGR of 6.6% during the forecast period.
Competition Scenario: Parenteral Packaging Market
Top parenteral packaging manufacturers are creating unique designs tailored to certain products or purposes. They are also committed to providing long-term solutions created from environmentally friendly and recyclable materials.
Several parenteral packaging companies are incorporating modern technology such as automation to increase product quality and save labor costs. Mergers, acquisitions, facility expansions, collaborations, distribution agreements, and partnerships are among the techniques used in the target market.
Recent Developments in the Parenteral Packaging Market-
• In December 2023, SCHOTT Pharma executed its expansion strategy and invested in a new production facility in Serbia.
• In October 2023, Gerresheimer introduced Cyclic Olefin Polymer vials for highly sensitive biologics like mRNA active ingredients.
• In 2023, BD, a prominent global medical technology business, introduced the all-in-one prefilled flush syringe with an integrated disinfection unit.
Browse the Complete Report: https://www.futuremarketinsights.com/reports/parenteral-packaging-market
Key Players
Schott AG; UDG Healthcare Plc.; Gerresheimer AG.; Becton, Dickinson and Company; Catalent Inc. Stevanato Group S.p.A; Baxter International Inc.; Nipro Corporation; West Pharmaceutical Services, Inc.; Adelphi Healthcare Packaging; Ypsomed Holding AG; Terumo Corporation; SiO2 Materials Science.; SGD Pharma; PCI Pharma Services; Ardena Holding NV; Berkshire Sterile Manufacturing; Akorn, Inc.; Alcami Corporation, Inc.; Berry Global Inc.
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Delaware, USA, and has its global delivery center in India. In addition to these, FMI also carries out business development and client engagement through its UK and UAE offices.
Parenteral Packaging Market to Reach USD 20,115.6 Million, Globally by 2034 at 4.6% CAGR: Future Market Insights, Inc. The global Parenteral Packaging Market value is expected to total USD 12,791.2 million by 2024. Over the forecast period, parenteral packaging demand is poised to grow with a CAGR of 4.6%, taking the total market valuation to USD 20,115.6 million by 2034. Parenteral packaging encompasses materials and systems designed for sterile pharmaceutical preparations administered via injection or infusion. These packaging solutions are vital in protecting drugs from contamination, ensuring stability, and facilitating safe administration. The escalating prevalence of chronic diseases and the subsequent rise in injectable therapies have significantly bolstered the demand for effective parenteral packaging solutions. Discover Market Opportunities – Get Your Sample of Our Industry Overview Today! https://www.futuremarketinsights.com/reports/sample/rep-gb-1258 Global Parenteral Packaging Market Expands as Demand for Injectable Drugs and Biologics Surges The parenteral packaging market is witnessing significant growth, driven by the rising demand for injectable drugs, biologics, and vaccines. With advancements in biopharmaceuticals and the increasing prevalence of chronic diseases, the need for safe, sterile, and high-quality packaging solutions has intensified. The surge in global vaccination programs, particularly in response to pandemics and infectious diseases, has further accelerated demand. Additionally, the pharmaceutical industry’s focus on patient safety, extended shelf life, and regulatory compliance has led to innovations in glass and plastic vials, ampoules, prefilled syringes, and IV containers. As the healthcare sector continues to expand, the demand for parenteral packaging is expected to rise, making it a critical component in ensuring drug efficacy and patient well-being. Key Trends Shaping the Parenteral Packaging Market 1. Innovation in Material Science – The industry is witnessing a transition toward advanced materials such as cyclic olefin polymers (COP) and cyclic olefin copolymers (COC), which provide superior moisture and oxygen barrier properties compared to conventional glass. 2. Prefilled Syringes in High Demand – The prefilled syringe segment is gaining immense traction due to its ability to reduce contamination risks, improve dosing accuracy, and enhance ease of use. With biologic drug formulations becoming more complex, pharmaceutical manufacturers are increasingly turning to prefilled solutions to streamline drug administration. Key Takeaways from the Global Parenteral Packaging Market • The global market for parenteral packaging is expected to total a valuation of USD 20,115.6 million in 2034. • By product type, the prefilled syringes segment is projected to grow at 5.3% CAGR through 2034. • Based on material, the plastic segment will likely hold a market share of 56.1% in 2034. • Sales in the United States are expected to soar at 3.0% CAGR through 2034.
• India is poised to register a CAGR of 6.6% during the forecast period. Competition Scenario: Parenteral Packaging Market Top parenteral packaging manufacturers are creating unique designs tailored to certain products or purposes. They are also committed to providing long-term solutions created from environmentally friendly and recyclable materials. Several parenteral packaging companies are incorporating modern technology such as automation to increase product quality and save labor costs. Mergers, acquisitions, facility expansions, collaborations, distribution agreements, and partnerships are among the techniques used in the target market. Recent Developments in the Parenteral Packaging Market• In December 2023, SCHOTT Pharma executed its expansion strategy and invested in a new production facility in Serbia. • In October 2023, Gerresheimer introduced Cyclic Olefin Polymer vials for highly sensitive biologics like mRNA active ingredients. • In 2023, BD, a prominent global medical technology business, introduced the all-in-one prefilled flush syringe with an integrated disinfection unit. Browse the Complete Report: https://www.futuremarketinsights.com/reports/parenteralpackaging-market Key Players Schott AG; UDG Healthcare Plc.; Gerresheimer AG.; Becton, Dickinson and Company; Catalent Inc. Stevanato Group S.p.A; Baxter International Inc.; Nipro Corporation; West Pharmaceutical Services, Inc.; Adelphi Healthcare Packaging; Ypsomed Holding AG; Terumo Corporation; SiO2 Materials Science.; SGD Pharma; PCI Pharma Services; Ardena Holding NV; Berkshire Sterile Manufacturing; Akorn, Inc.; Alcami Corporation, Inc.; Berry Global Inc. Global Parenteral Packaging Market by Category By Product: • Vials • Prefilled Syringes • Bags • Ampoules • Ready to Use System By Material: • Glass • Plastic o PVC o Polyolefin
By Packaging Format: • Small Volume • Large Volume By Region: • North America • Latin America • Asia Pacific Excluding Japan • Western Europe • Eastern Europe • Middle East & Africa • Japan About Future Market Insights (FMI) Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Contact Us: Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-347-918-3531 For Sales Enquiries: [email protected] Website: https://www.futuremarketinsights.com LinkedIn| Twitter| Blogs | YouTube